Autolus Therapeutics plc Cash
Autolus Therapeutics plc (AUTL) had Cash of $382.44 million as of 2022-12-31, per its 20-F filed 2023-03-07.
Discontinued › Balance Sheet › Assets
us-gaap:Cash · last filed 2023-03-07
- 2022-12-31: Cash $382.44M.
- 2021-12-31: Cash $310.34M.
- 2021-03-31: Cash $239.01M.
- 2020-12-31: Cash $153.30M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2022-12-31 | $382.44M 20-F · filed 2023-03-07 | |
| 2021-12-31 | $310.34M 20-F · filed 2023-03-07 | |
| 2021-03-31 | $239.01M 6-K · filed 2021-05-06 | |
| 2020-12-31 | $153.30M 20-F · filed 2023-03-07 | |
| 2020-09-30 | $177.69M 6-K · filed 2020-11-05 | |
| 2020-06-30 | $212.04M 6-K · filed 2020-08-06 | |
| 2020-03-31 | $243.31M 6-K · filed 2021-05-06 | |
| 2019-12-31 | $210.64M 20-F · filed 2022-03-10 | |
| 2019-09-30 | $229.37M 6-K · filed 2020-11-05 | |
| 2019-06-30 | $266.19M 6-K · filed 2020-08-06 | |
| 2019-03-31 | $187.73M 6-K · filed 2020-05-07 | |
| 2018-12-31 | $217.45M 20-F · filed 2021-03-04 | |
| 2018-09-30 | $246.98M 20-F · filed 2021-03-04 | $247.09M 20-F · filed 2018-11-23 |
| 2018-06-30 | $264.92M 6-K · filed 2019-08-08 | |
| 2017-12-31 | $128.98M 20-F · filed 2019-02-25 | |
| 2017-09-30 | $137.07M 20-F · filed 2020-03-03 | |
| 2016-09-30 | $28.06M 20-F · filed 2019-02-25 | |
| 2015-09-30 | $10.20M 20-F · filed 2018-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |